logo

Novavax Inc. (NVAX)



Trade NVAX now with
  Date
  Headline
3/24/2020 6:07:45 AM Novavax Says NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
3/10/2020 5:48:47 AM Novavax: CEPI Awards Initial Funding Of $4 Mln For COVID-19 Vaccine Development
2/26/2020 10:48:19 AM Stock Alert: Novavax Gains 25%
1/15/2020 8:53:34 AM Novavax Says FDA Granted Fast Track Designation For NanoFlu
10/15/2019 7:15:20 AM Novavax Initiates Pivotal Phase 3 Clinical Trial Of NanoFlu Influenza Vaccine In Older Adults
6/27/2019 7:16:31 AM Novavax Confirms Accelerated Approval Pathway Available For Licensure Of NanoFlu
  
 
>